ArticleEBioMedicine2016

ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease.

Florent Letronne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.